Adam M. Burgoyne - Concepedia

Author

Adam M. Burgoyne

University of California San Diego ORCID

Also Known As

A. Burgoyne, Adam Burgoyne, Adam M Burgoyne, Adam M. Burgoyne, Anthony Barron, Burgoyne, Adam, Oleksandr Vynnychenko, Risna Haq

110

Publications

5.1K

Citations

H-Index

Concepts

All Affiliations

University of California San Diego University of California, Los Angeles Moores Cancer Center UC San Diego Health System Oregon Health & Science University

About

Adam M. Burgoyne is an author at University of California San Diego specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	3.2K
2	Health Sciences	3	3	1.3K
3	Natural Sciences	2	2	173
4	Public Health	1	1	77
5	Biology	1	1	140

Adam M. Burgoyne

Publications

Citations

H-Index

Page 1

	Year	Citations
Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology Al B. Benson, Michael I. D’Angelica, Daniel E. Abbott, Journal of the National Comprehensive Cancer Network Surgical OncologyCancer ManagementPathologyCholangiopathiesNccn Guidelines Recommendations	2021	999
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial Robin Kate Kelley, Makoto Ueno, Changhoon Yoo, The Lancet UrologySurgical OncologyGastrointestinal OncologyMedicineBiliary Cancer	2023	891
Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma Andrew X. Zhu, Alexander R. Abbas, Marina Ruiz de Galarreta, Nature Medicine MedicineImmunologyMolecular CorrelatesPathologyImmune Checkpoint Inhibitor	2022	580
FGFR1 and NTRK3 actionable alterations in “Wild-Type” gastrointestinal stromal tumors Eileen Shi, Juliann Chmielecki, Chih‐Min Tang, Journal of Translational Medicine	2016	218
NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023 Al B. Benson, Michael I. D’Angelica, Thomas A. Abrams, Journal of the National Comprehensive Cancer Network Nccn Guidelines® InsightsMolecular TestingSurgical OncologySeparate GuidelinesGastroenterology	2023	184
Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study Bruno Sangro, Masatoshi Kudo, Joseph P. Erinjeri, The Lancet HepatologyTransarterial ChemoembolisationMedicinePharmacologyPathology	2025	151
Molecular phylogeny of Pholadoidea Lamarck, 1809 supports a single origin for xylotrophy (wood feeding) and xylotrophic bacterial endosymbiosis in Bivalvia Daniel L. Distel, Mehwish Amin, Adam M. Burgoyne, Molecular Phylogenetics and Evolution Wood FeedingMicrobial EvolutionPhylogenetic AnalysisPhylogeneticsMolecular Ecology	2011	140
CelAB, a Multifunctional Cellulase Encoded by <i>Teredinibacter turnerae</i> T7902 <sup>T</sup> , a Culturable Symbiont Isolated from the Wood-Boring Marine Bivalve <i>Lyrodus pedicellatus</i> Nathan A. Ekborg, Wendy Morrill, Adam M. Burgoyne, Applied and Environmental Microbiology	2007	81
Increased risk of additional cancers among patients with gastrointestinal stromal tumors: A population‐based study James D. Murphy, L. Grace, Joel Baumgartner, Cancer Surgical OncologyEpidemiology Of CancerGastroenterologyPathologyGastric Adenocarcinoma	2015	77
Comprehensive genomic landscape and precision therapeutic approach in biliary tract cancers Ryosuke Okamura, Razelle Kurzrock, Robert J. Mallory, International Journal of Cancer Biliary Tract CancersPathologyCtdna Vs Tp53Tumor BiologyOncology	2020	71

Page 1